Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Keith G Tolman, Jane Chandramouli & John C Fang. (2000) Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Expert Opinion on Pharmacotherapy 1:6, pages 1171-1194.
Read now
Read now
K. Kubo, A. Uehara, T. Kubota, T. Nozu, M. Moriya, Y. Watanabe, E. Shoji, S. B. Santos, K. Harada & Y. Kohgo. (1995) Effects of Ranitidine on Gastric Vesicles Containing H+, K+-Adenosine Triphosphatase in Rats. Scandinavian Journal of Gastroenterology 30:10, pages 944-951.
Read now
Read now
A. Lee. (1994) Future Research in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 29:sup205, pages 51-58.
Read now
Read now
A. Peetsalu, H.-I. Maaroos, P. Sipponen & M. Peetsalu. (1991) Long-Term Effect of Vagotomy on Gastric Mucosa and Helicobacter pylori in Duodenal Ulcer Patients. Scandinavian Journal of Gastroenterology 26:sup186, pages 77-83.
Read now
Read now
P. Sipponen. (1991) Helicobacter pylori and Chronic Gastritis: An Increased Risk of Peptic Ulcer? A Review. Scandinavian Journal of Gastroenterology 26:sup186, pages 06-10.
Read now
Read now
P. Sipponen, K. Varis, O. Fräki, U.-M. Korri, K. Seppälä & M. Siurala. (1990) Cumulative 10-Year Risk of Symptomatic Duodenal and Gastric Ulcer in Patients with or without Chronic Gastritis: A Clinical Follow-up Study of 454 Outpatients. Scandinavian Journal of Gastroenterology 25:10, pages 966-973.
Read now
Read now
Pentti Sipponen. (1990) Chronic Gastritis and Ulcer Risk. Scandinavian Journal of Gastroenterology 25:3, pages 193-196.
Read now
Read now
Articles from other publishers (35)
Hans-Peter Wirth & Manqiao Yang. (2016) Different Pathophysiology of Gastritis in East and West? A Western Perspective. Inflammatory Intestinal Diseases 1:3, pages 113-122.
Crossref
Crossref
Nayoung Kim & Yo Han Park. 2016. Helicobacter pylori. Helicobacter pylori
187
206
.
Yo Han Park & Nayoung Kim. (2015) Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. Journal of Cancer Prevention 20:1, pages 25-40.
Crossref
Crossref
Gregory Kaltsas, Simona Grozinsky-Glasberg, Krystallenia I. Alexandraki, Dimitrios Thomas, Apostolos V. Tsolakis, David Gross & Ashley B. Grossman. (2014) Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clinical Endocrinology 81:2, pages 157-168.
Crossref
Crossref
Mariam Abdullahi Adamu, Melanie Nicole Weck, Dietrich Rothenbacher & Hermann Brenner. (2011) Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow‐up of a population‐based cohort study. International Journal of Cancer 128:7, pages 1652-1658.
Crossref
Crossref
Mariam Abdullahi Adamu, Melanie Nicole Weck, Lei Gao & Hermann Brenner. (2010) Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. European Journal of Epidemiology 25:7, pages 439-448.
Crossref
Crossref
Rolv-Ole Lindsetmo, Tor Jac Eide, Roar Johnsen & Arthur Revhaug. (2008) Helicobacter pylori-Induced Damage to the Gastric Mucosa is Not Modulated by Previous Vagotomy or Medical Treatment of Peptic Ulcer Disease: A Comparative Study of Vagotomized Patients, Medically Treated Peptic Ulcer Patients and Community Control Subjects. World Journal of Surgery 32:10, pages 2267-2274.
Crossref
Crossref
Lea Veijola, Anna Sankila, Hilpi Rautelin, Timo U. Kosunen, Pentti Sipponen, Hannu Hyv??rinen, Reijo Tilvis, Seppo Sarna, Perttu E. T. Arkkila & Kari Sepp??l??. (2006) Clinical Significance of Widespread Gastric Metaplasia in the Duodenal Bulb. Journal of Clinical Gastroenterology 40:6, pages 510-514.
Crossref
Crossref
T. Kamada, J. Hata, H. Kusunoki, K. Sugiu, M. Ito, S. Tanaka, Y. Kawamura, K. Chayama & K. Haruma. (2005) Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease. Alimentary Pharmacology and Therapeutics 21:s2, pages 99-104.
Crossref
Crossref
S. ZUCOLOTO, L. M. F. ROMANELLOS. B. GARCIA, L. F. R. SOBREIRA, A. J. A. BARBOSA & L. E. A. TRONCON. (2003) Topical application of benzalkonium chloride to the stomach serosa increases gastric emptying time, acid secretion, serum gastrin and size of the mucosa. APMIS 110:11, pages 795-801.
Crossref
Crossref
S. Sanduleanu, D. Jonkers, A. de Bruïne, W. Hameeteman & R.W. Stockbrügger. (2001) Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Digestive and Liver Disease 33:8, pages 707-719.
Crossref
Crossref
S. Sanduleanu, D. Jonkers, A. De Bruine, W. Hameeteman & R. W. Stockbrügger. (2008)
Non‐
Helicobacter pylori
bacterial flora during acid‐suppressive therapy: differential findings in gastric juice and gastric mucosa
. Alimentary Pharmacology & Therapeutics 15:3, pages 379-388.
Crossref
Crossref
A. Cats & E. J. Kuipers. 2001. Barrett’s Esophagus. Barrett’s Esophagus
81
105
.
Manfred Stolte & Alexander Meining. (2000) Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 118:1, pages 242-243.
Crossref
Crossref
M. F. Dixon, A. Lee & S. J. O. Veldhuyzen Van Zanten. 2000. Helicobacter pylori. Helicobacter pylori
327
338
.
E. J. Kuipers & S. G. M. Meuwissen. 2000. Helicobacter pylori. Helicobacter pylori
255
267
.
Lars Lundell, Pekka Miettinen, Helge E. Myrvold, Sven A. Pedersen, Kjell Thor, Annelie Andersson, Jan Hattlebakk, Niilo Havu, Eero Janatuinen, Kristina Levander, Bengt Liedman & Per Nyström. (1999) Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 117:2, pages 319-326.
Crossref
Crossref
Sander J.O. Veldhuyzen van Zanten, Michael F. Dixon & Adrian Lee. (1999) The gastric transitional zones: Neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 116:5, pages 1217-1229.
Crossref
Crossref
Nayoung Kim, Seon Hee Lim, Kye Heui Lee & Shin Eun Choi. (1998) Long-Term Effect of Helicobacter pylori Eradication on Gastric Metaplasia in Patients With Duodenal Ulcer. Journal of Clinical Gastroenterology 27:3, pages 246-252.
Crossref
Crossref
Meining, Kiel & Stolte. (1998) Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. Alimentary Pharmacology & Therapeutics 12:8, pages 735-740.
Crossref
Crossref
Harry Hua-Xiang Xia & Nicholas J Talley. (1998) Helicobacter pylori Infection, Reflux Esophagitis, and Atrophic Gastritis: An Unexplored Triangle. American Journal of Gastroenterology 93:3, pages 394-400.
Crossref
Crossref
Stolte, Meining, Schmitz, Alexandridis & Seifert. (2001)
Changes in
Helicobacter pylori
‐induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro‐oesophageal reflux disease
. Alimentary Pharmacology & Therapeutics 12:3, pages 247-253.
Crossref
Crossref
A. Meining, H. Bosseckert, W. F. Caspary, C. Nauert & M. Stolte. (1997) H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients. Alimentary Pharmacology and Therapeutics 11:4, pages 729-734.
Crossref
Crossref
E. de Koster, C. L. Jonas, M. Ferhat, P. Denis, M. Buset & M. Deltenre. (1997) Helicobacter pylori doit-il être éradiqué avant de prescrire un traitement à long terme par un inhibiteur de pompe à protons pour une œsophagite par reflux?ShouldHelicobacter pylori be eradicated before starting a long term proton pump inhibitor treatment for reflux oesophagitis?. Acta Endoscopica 27:3, pages 201-211.
Crossref
Crossref
EJ Kuipers & BJ Appelmelk. (1997) Helicobacter pylori and atrophic gastritis. Biomedicine & Pharmacotherapy 51:4, pages 150-155.
Crossref
Crossref
A W Harris, P A Gummett, M M Walker, J J Misiewicz & J H Baron. (1996) Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb.. Gut 39:4, pages 513-520.
Crossref
Crossref
Ernst J. Kuipers, Lars Lundell, Elly C. Klinkenberg-Knol, Niilo Havu, Henk P.M. Festen, Bengt Liedman, Cornelius B.H.W. Lamers, Jan B.M.J. Jansen, Jan Dalenbäck, Pleun Snel, G. Frits Nelis & Stephan G.M. Meuwissen. (1996)
Atrophic Gastritis and
Helicobacter pylori
Infection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication
. New England Journal of Medicine 334:16, pages 1018-1022.
Crossref
Crossref
J. W. Freston. 1996. Helicobacter pylori. Helicobacter pylori
245
254
.
V Savarino, G S Mela, G Celle & S Vigneri. (1995) Gastric metaplasia and Helicobacter pylori infection.. Gut 37:3, pages 445-446.
Crossref
Crossref
E. J. KUIPERS, A. LEE, E. C. KLINKENBERG‐KNOL & S. G. M. MEUWISSEN. (2007) The development of atrophic gastritis—Helicobacter pylori and the effects of acid suppressive therapy. Alimentary Pharmacology & Therapeutics 9:4, pages 331-340.
Crossref
Crossref
S Khulusi, M A Mendall, S Badve, P Patel, C Finlayson & T C Northfield. (1995) Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum.. Gut 36:2, pages 193-197.
Crossref
Crossref
A. Lee & H. Mitchell. 1994. Helicobacter pylori. Helicobacter pylori
59
72
.
P. Sipponen. 1991. Helicobacter pylori 1990. Helicobacter pylori 1990
113
119
.
J. G. PENSTON, J. S. DIXON, S. A. M. SELWAY & K. G. WORMSLEY. (2007) Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidine. Alimentary Pharmacology & Therapeutics 4:4, pages 381-392.
Crossref
Crossref
J. C. Debongnie. (1990) La gastrite type B: une gastrite bactérienne: réalité ou fantaisie ?Type B gastritis is bacterial gastritis: fact or fancy ?La gastritis tipo B: una gastritis bacteriana: realidad o ficcion ?. Acta Endoscopica 20:4, pages 415-425.
Crossref
Crossref